doxorubicin hydrochloride, liposomal

Generic: doxorubicin hydrochloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE Inactive Finished

Drug Facts

Product Profile

Brand Name doxorubicin hydrochloride, liposomal
Generic Name doxorubicin hydrochloride
Labeler baxter healthcare corporation
Dosage Form INJECTION, SUSPENSION, LIPOSOMAL
Routes
INTRAVENOUS
Active Ingredients

doxorubicin hydrochloride 2 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 0338-9581
Product ID 0338-9581_a4227051-225f-49e2-9e5c-653ea0f99739
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Listing Expiration 2026-12-31
Marketing Start 2023-12-19

Pharmacologic Class

Classes
anthracycline topoisomerase inhibitor [epc] anthracyclines [cs] topoisomerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03389581
Hyphenated Format 0338-9581

Supplemental Identifiers

RxCUI
1790115
UPC
5413765812286
UNII
82F2G7BL4E

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxorubicin hydrochloride, liposomal (source: ndc)
Generic Name doxorubicin hydrochloride (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02) / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01)
source: ndc

Packages (1)

0338-9581-02 1 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02) / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01)

Ingredients (1)

doxorubicin hydrochloride (2 mg/mL)

Linked Drug Pages (1)

doxorubicin hydrochloride, Liposomal ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "a4227051-225f-49e2-9e5c-653ea0f99739", "openfda": {"upc": ["5413765812286"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115"], "spl_set_id": ["b24afa8c-636b-4ace-99d5-51f445ad3123"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02)  / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01)", "package_ndc": "0338-9581-02", "marketing_start_date": "20231219"}], "brand_name": "doxorubicin hydrochloride, Liposomal", "product_id": "0338-9581_a4227051-225f-49e2-9e5c-653ea0f99739", "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0338-9581", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "doxorubicin hydrochloride, Liposomal", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE", "marketing_start_date": "20231219", "listing_expiration_date": "20261231"}